U.S. Women's Health Market Size & Outlook, 2026-2033

The women's health market in the United States is expected to reach a projected revenue of US$ 19,690.2 million by 2033. A compound annual growth rate of 2.8% is expected of the United States women's health market from 2026 to 2033.
Revenue, 2025 (US$M)
$15,219.2
Forecast, 2033 (US$M)
$19,690.2
CAGR, 2026 - 2033
2.8%
Report Coverage
U.S.

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

U.S. women's health market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

U.S. women's health market highlights

  • The U.S. women's health market generated a revenue of USD 15,219.2 million in 2025 and is expected to reach USD 19,690.2 million by 2033.
  • The U.S. market is expected to grow at a CAGR of 2.8% from 2026 to 2033.
  • In terms of segment, contraceptives was the largest revenue generating application in 2025.
  • Menopause is the most lucrative application segment registering the fastest growth during the forecast period.


Women's health market data book summary

Market revenue in 2025USD 15,219.2 million
Market revenue in 2033USD 19,690.2 million
Growth rate2.8% (CAGR from 2026 to 2033)
Largest segmentContraceptives
Fastest growing segmentMenopause
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationHormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, Polycystic Ovary Syndrome (PCOS)
Key market players worldwideAbbVie Inc, Bayer AG, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Agile Therapeutics Inc, Amgen Inc, Apothecus, Blairex Laboratories, Ferring


Other key industry trends

  • In terms of revenue, U.S. accounted for 28.5% of the global women's health market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In North America, U.S. women's health market is projected to lead the regional market in terms of revenue in 2033.
  • Mexico is the fastest growing regional market in North America and is projected to reach USD 4,491.3 million by 2033.

Contraceptives was the largest segment with a revenue share of 29.52% in 2025. Horizon Databook has segmented the U.S. women's health market based on hormonal infertility, contraceptives, postmenopausal osteoporosis, endometriosis & uterine fibroids, menopause, polycystic ovary syndrome (pcos) covering the revenue growth of each sub-segment from 2021 to 2033.


In the U.S., women, especially in the age group of 19 to 50 years, are increasingly becoming health conscious owing to the growing incidence of chronic diseases, which is also one of the significant factors boosting the adoption of women’s health therapeutics in the country.

The increase in the population of women aged 65 and above is leading to a rise in the prevalence of medical conditions associated with aging such as osteoporosis and menopause. By 2050, the population of women aged 65 and above is expected to increase by 81%.

Moreover, increase in the number of women suffering from osteoporosis, obesity, depression, & menstrual disorders and high awareness in the target population are among the factors driving the market.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Women's Health Market Companies

Name Profile # Employees HQ Website
Apothecus View profile 11-50 Hicksville, New York, United States, North America https://apothecus.com
Blairex Laboratories View profile 101-250 Columbus, Indiana, United States, North America http://www.blairex.com
Agile Therapeutics Inc View profile 19 500 College Road East, Suite 310, Princeton, NJ, United States, 08540 https://www.agiletherapeutics.com
Ferring View profile 5001-10000 Saint-prex, Vaud, Switzerland, Europe https://www.ferring.com
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
AbbVie Inc View profile 50000 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 http://www.abbvieinvestor.com
Amgen Inc View profile 26700 One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 https://www.amgen.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com

U.S. women's health market size, by application, 2021-2033 (US$M)

U.S. Women's Health Market Outlook Share, 2025 & 2033 (US$M)

U.S. women's health market size, by application, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online